handshake
IT

Teva taps IBM Watson for drug repurposing project

by Nick Paul Taylor

Teva and IBM have formed a three-year, Watson-enabled drug repurposing collaboration

DNA
IT

Ginkgo inks biosensor pact to speed strain development

by Nick Paul Taylor

Ginkgo Bioworks has teamed up with Prospect Bio to incorporate biosensors into its organism design process.

IT

Emulate bumps up Series B to $45M, lands Covance deal

by Nick Paul Taylor

Organ-on-a-chip player Emulate has added $17 million to its Series B round and landed a deal with Covance.

White House
IT

Obama-chaired council calls for international cooperation on use of AI in

by Nick Paul Taylor

A council chaired by President Obama has called for countries to cooperate to investigate the potential uses of artificial intelligence in healthcare.

Cambridge, UK
IT

Well-connected IT-enabled drug repurposing shop raises cash for rare dise

by Nick Paul Taylor

Amadeus Capital and Jonathan Milner have teamed up to invest in Healx, a startup working with patient advocacy groups to repurpose drugs for rare diseases.

IT

Sanofi-partnered Recursion raises $13M for tech-enabled R&D drive

by Nick Paul Taylor

Recursion Pharmaceuticals has raised $12.9 million to scale up its computer-driven approach to drug development.

IT

IBM, NSF and UCSF team up to apply AI to synthetic biology, create cell d

by Nick Paul Taylor

UC San Francisco has landed $24 million in National Science Foundation funding to set up the Center for Cellular Construction.

IT

After raising $100M and inking an Alzheimer’s pact, BenevolentAI buys a s

by Nick Paul Taylor

British startup BenevolentAI has become the first European firm to install a purpose-built version of the DGX-1, a supercomputer designed for deep learning.